HEXO Corp (TSX: HEXO; NYSE: HEXO) rescheduled its fourth-quarter earnings results to October 28 in light of the financing and additional time
Categories
Cannabis
Aphria’s impressive Q1 earnings send the cannabis stock soaring
Shares of Aphria Inc (NYSE: APHA) shot up 19% during pre-market hours on Tuesday after it reported better-than-expected first-quarter earnings, in turn, healing
Can Aphria pull off another blockbuster quarterly earnings next week?
When Aphria Inc (NYSE: APHA) last reported quarterly results on August 1, the stock rallied almost 41% driven by an increase in
Hexo stock plunges to a new low after reporting preliminary Q4 results; withdraws FY20 outlook
Shares of HEXO Corp (TSX: HEXO; NYSE: HEXO) plummeted to a new yearly low today after the company reported preliminary results for
Aphria, Canopy Growth, Aurora Cannabis bow to pressure from vaping fatalities
Leading players in the cannabis industry were bleeding on Monday after the Centers for Disease Control and Prevention (CDC) revealed that it
Tilray lingers near a yearly low as lack of clarity about pot industry continues
Tilray Inc. (NASDAQ: TLRY) stock is trading near the yearly low on Wednesday after falling over 64% in the year so far
Research Tear Sheet: Village Farms International (VFF) stock
Last year, Canada became the breeding ground for numerous pot stocks following the country’s decision to legalize the use of marijuana for
CannTrust may be cheap, but stay away from this pot stock
Shares of CannTrust Holdings (NYSE: CTST) have plunged over 80% in the past 12 months, making it quite cheap with respect to
Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0
Both Aurora Cannabis (NYSE: ACB) and Canopy Growth Corporation (NYSE: CGC) have reported disappointing quarterly results in the most recent quarter. Share
Aurora Cannabis stock drops after reporting Q4 results
Aurora Cannabis (NYSE: ACB) reported fourth quarter 2019 results and the topline missed the company's estimates. ACB stock, which closed up 3.34%
What to expect from Aurora Cannabis Q4 earnings
Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB) is slated to report its fourth-quarter results on September 11 after the bell followed by
Pot giants gain on DEA announcement; GW Pharmaceuticals continues to decline
Marijuana giants received a major boost on Monday after the US Drug Enforcement Administration (DEA) announced that it would initiate steps to
Earnings preview: Asset write-downs likely to hurt Aphria in Q4
Aphria Inc. (NYSE: APHA and TSX: APHA) is set to release its earnings results for the fourth quarter of 2019 on Thursday
Constellation Brands slips to a loss in Q1 but beats estimates
Constellation Brands (NYSE: STZ) slipped to a loss in the first quarter of fiscal 2020 from a profit last year, due to
Earnings preview: Will Canopy Growth post upbeat Q4 2019 results?
Canopy Growth (TSX: WEED, NYSE: CGC) is scheduled to release its financial results for the fourth fiscal quarter of 2019 after the
Harborside stock heads lower after going public
The stock trend of California-centric cannabis company Harborside Inc. heads lower after going public on Monday under the "HBOR" ticker on the
Tilray stock heads downward on doubts of cannabis risks
Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. The stock has been on a downward trend since
Canopy Growth names Constellation Brands veteran as acting CFO
Image by Rex Medlen from Pixabay Shares of Canopy Growth Corporation (NYSE: CGC) gained over 2% on Tuesday after the cannabis giant
The question every pot investor asks himself – Aurora Cannabis or Hexo?
If you have already missed the train, there is no denying the fact that NOW is the time to enter the lucrative
Marijuana vs US: Will Aurora Cannabis survive in the banned market?
In the US, marijuana has been slowly turning to be legal in certain states but it still remained banned at the federal
Aurora Cannabis appoints activist billionaire investor Nelson Peltz as strategic advisor
Aurora Cannabis (ACB) stock surged more than 10% in the pre-market trading as the company appointed activist investor Nelson Peltz as its